Agilent Technologies (A) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Nov 25, 2026 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Mikael Dolsten, Director sold 634 shares at $151.38 ($96K).
- Trade date
- Sep 4, 2026
- Disclosed to the SEC
- Sep 9, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All A insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
A insider transactions (Form 4)
Open-market purchases and sales. 91 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 9SEC | Mikael DolstenDirector | Sell | 6344,924 held (−11%) | $151.38 | $96K | +13.2% | — |
| Jun 2SEC | Mikael DolstenDirector | Sell | 1,6005,548 held (−22%) | $135.42 | $217K | +26.5% | — |
| Dec 3SEC | Mikael DolstenDirector | Sell | 2,6004,973 held (−34%) | $149.81 | $390K | +14.4% | — |
| Dec 1SEC | Rodney GonsalvesV.P., Corporate Controller | Sell | 3,00031,846 held (−9%) | $154.99 | $465K | +10.5% | — |
| Nov 20SEC | Padraig McDonnellCEO, President | Sell Plan | 91132,058 held (−3%) | $143.24 | $130K | +19.6% | — |
| Nov 14SEC | Padraig McDonnellCEO, President | Sell Plan | 12,49033,448 held (−27%) | $150.00 | $1.9M | +14.2% | — |
Similar past setups: not applicable. A has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with A in the Research Lab
A has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Agilent Technologies insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $1.3M of A stock on the open market; P/E 34.1 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
A insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $96K | 1 |
| Q2 2026 | — | 0 | $217K | 1 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $2.9M | 4 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Agilent Technologies insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $1.3M. 2 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
A earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 26, 2026 | +4.1% | None | +1.9%S&P +0.7% | +9.6% |
| May 27, 2026 | +3.2% | None | +17.6%S&P +0.5% | +0.5% |
| Feb 25, 2026 | -2.4% | None | -2.8%S&P +0.3% | -8.9% |
| Nov 24, 2025 | +2.5% | Sold $2.0M | +3.9%S&P +2.4% | -12.0% |
| Aug 27, 2025 | +3.7% | None | +5.6%S&P +0.6% | -1.3% |
| May 28, 2025 | -3.7% | None | +1.8%S&P -0.2% | +5.2% |
| Feb 26, 2025 | -6.6% | None | -5.3%S&P -1.5% | -8.2% |
| Nov 25, 2024 | -4.1% | None | +0.4%S&P +0.9% | +1.1% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
A short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded A
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Thomas H TubervilleSenate | Sold $1,001 - $15,000 | May 3, 2024 | Aug 5, 2026 | +25.2% |
Insiders at Agilent Technologies
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Padraig McDonnellCEO, President | — | $2.0M | Nov 19, 2026 | — | — |
| Mikael DolstenDirector | — | $702K | Sep 9, 2026 | — | — |
| Rodney GonsalvesV.P., Corporate Controller | — | $465K | Dec 1, 2025 | — | — |
| Simon MayPresident | — | — | Nov 19, 2026 | — | — |
| Jonah Prevost KirkwoodPresident | — | — | Nov 19, 2026 | — | — |
| Angelica RiemannPresident | — | — | Nov 19, 2026 | — | — |
| Adam Stewart ElinoffCFO, President | — | — | Nov 19, 2026 | — | — |
| Jianmiao Mike ZhangPresident | — | — | Nov 19, 2026 | — | — |
| Meghan HensonPresident | — | — | Nov 19, 2026 | — | — |
| Glenn S. BoehnleinDirector | — | — | Sep 10, 2026 | — | — |
| Michael Steven BucknerPresident | — | — | May 21, 2026 | — | — |
| Mala AnandDirector | — | — | Mar 23, 2026 | — | — |
| Judy L. BrownDirector | — | — | Mar 23, 2026 | — | — |
| Boon Hwee KohDirector | — | — | Mar 23, 2026 | — | — |
| Daniel K. PodolskyDirector | — | — | Mar 23, 2026 | — | — |
| Dow R. WilsonDirector | — | — | Mar 23, 2026 | — | — |
| Pascal SoriotDirector | — | — | Mar 23, 2026 | — | — |
| George A. ScangosDirector | — | — | Mar 23, 2026 | — | — |
| Otis W. BrawleyDirector | — | — | Mar 23, 2026 | 0 of 1 | — |
| Sue H. RatajDirector | — | — | Mar 23, 2026 | — | — |
| Bret DimarcoPresident | — | — | Dec 1, 2025 | — | — |
Board links: companies that share insiders with A
Directors and executives who filed Form 4s for A and another company in the last 12 months.
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
A stock: common questions
Are Agilent Technologies insiders buying A stock?
No. No Agilent Technologies insider reported an open-market purchase of A in the past 12 months.
Are Agilent Technologies insiders selling A stock?
3 insiders reported sales worth $1.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is A's P/E ratio?
A trades at about 34.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is A's 52-week range?
Over the past year A has traded between $109.61 and $181.48. It last closed at $171.33 on Nov 20, 2026.